U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C14H19NO2.ClH
Molecular Weight 269.767
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PIPEROXAN HYDROCHLORIDE

SMILES

Cl.C(C1COC2=C(O1)C=CC=C2)N3CCCCC3

InChI

InChIKey=BITRJBQGQMGGQI-UHFFFAOYSA-N
InChI=1S/C14H19NO2.ClH/c1-4-8-15(9-5-1)10-12-11-16-13-6-2-3-7-14(13)17-12;/h2-3,6-7,12H,1,4-5,8-11H2;1H

HIDE SMILES / InChI

Molecular Formula C14H19NO2
Molecular Weight 233.3062
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Piperoxan is the first antihistamine was discovered. Piperoxan protected guinea pigs against histamine-induced bronchospasm. The piperoxan has been used to provoke anxiety behaviors in the monkey. Piperoxan is an alpha-adrenergic antagonist. Piperoxan has been claimed to preferentially block presynaptic alpha-adrenoreceptors leading to an increase in noradrenaline release and by this way the postsynaptic alpha-adrenoreceptors blockade may be overcome. There was clear evidence that piperoxan enhanced myocardial performance. Piperoxan is a diagnostic aid used in studies of hypertension.

Approval Year

Doses

Doses

DosePopulationAdverse events​
10 mg single, intravenous
Recommended
Dose: 10 mg
Route: intravenous
Route: single
Dose: 10 mg
Sources:
unhealthy, adult
n = 1
Health Status: unhealthy
Condition: overdose of adrenaline (5 mg)
Age Group: adult
Sex: unknown
Population Size: 1
Sources:
15 mg single, intravenous
Recommended
Dose: 15 mg
Route: intravenous
Route: single
Dose: 15 mg
Sources:
unhealthy, adult
n = 62
Health Status: unhealthy
Condition: hypertension
Age Group: adult
Sex: unknown
Population Size: 62
Sources:
Other AEs: Pulse rapid...
Other AEs:
Pulse rapid (16 patients)
Sources:
AEs

AEs

AESignificanceDosePopulation
Pulse rapid 16 patients
15 mg single, intravenous
Recommended
Dose: 15 mg
Route: intravenous
Route: single
Dose: 15 mg
Sources:
unhealthy, adult
n = 62
Health Status: unhealthy
Condition: hypertension
Age Group: adult
Sex: unknown
Population Size: 62
Sources:
PubMed

PubMed

TitleDatePubMed
Differentiation of drugs acting centrally upon the cardiovascular system by means of sympathetic and vagal responses.
1978
Pharmacological characteristics of spinal alpha-adrenoreceptors in rats.
1981 Mar
Role of alpha-2 adrenergic receptors in anti-ulcer effect mechanism of estrogen and luteinising hormone on rats.
2009 Apr
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:56:59 GMT 2023
Edited
by admin
on Fri Dec 15 18:56:59 GMT 2023
Record UNII
KS0DZ1UQNW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PIPEROXAN HYDROCHLORIDE
Common Name English
PIPEROXAN HCL
Common Name English
PIPERIDINE, 1-((2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)METHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
F-933 HYDROCHLORIDE
Code English
COMPD. 933F
Common Name English
PIPERIDINE, 1-((2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)METHYL)-, HYDROCHLORIDE
Systematic Name English
933F HYDROCHLORIDE
Code English
DL-PIPEROXAN HYDROCHLORIDE
Common Name English
FOURNEAU-933 HYDROCHLORIDE
Common Name English
BENODAINE HYDROCHLORIDE
Common Name English
2-(1-PIPERIDYLMETHYL)-1,4-BENZODIOXAN HYDROCHLORIDE
Systematic Name English
PIPERIDINE, 1-(1,4-BENZODIOXAN-2-YLMETHYL)-, HYDROCHLORIDE
Systematic Name English
BENZODIOXANE HYDROCHLORIDE
Systematic Name English
2-PIPERIDINOMETHYL-1,4-BENZODIOXAN HYDROCHLORIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29713
Created by admin on Fri Dec 15 18:56:59 GMT 2023 , Edited by admin on Fri Dec 15 18:56:59 GMT 2023
Code System Code Type Description
PUBCHEM
101619
Created by admin on Fri Dec 15 18:56:59 GMT 2023 , Edited by admin on Fri Dec 15 18:56:59 GMT 2023
PRIMARY
EPA CompTox
DTXSID00928851
Created by admin on Fri Dec 15 18:56:59 GMT 2023 , Edited by admin on Fri Dec 15 18:56:59 GMT 2023
PRIMARY
CAS
6211-27-4
Created by admin on Fri Dec 15 18:56:59 GMT 2023 , Edited by admin on Fri Dec 15 18:56:59 GMT 2023
SUPERSEDED
CAS
135-87-5
Created by admin on Fri Dec 15 18:56:59 GMT 2023 , Edited by admin on Fri Dec 15 18:56:59 GMT 2023
PRIMARY
FDA UNII
KS0DZ1UQNW
Created by admin on Fri Dec 15 18:56:59 GMT 2023 , Edited by admin on Fri Dec 15 18:56:59 GMT 2023
PRIMARY
NCI_THESAURUS
C81370
Created by admin on Fri Dec 15 18:56:59 GMT 2023 , Edited by admin on Fri Dec 15 18:56:59 GMT 2023
PRIMARY
ECHA (EC/EINECS)
205-222-3
Created by admin on Fri Dec 15 18:56:59 GMT 2023 , Edited by admin on Fri Dec 15 18:56:59 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY